The purpose of this full-day training is to provide participants with a detailed overview of medications that have been shown to be effective as a component of the treatment of lca ohol and opioid use disorders. Topics will include: the context for medication-assisted 
treatment (positive and negative perceptions), the epidemiology of alcohol and opioid use and dependence (user demographics), a review of the various classes of opioids, an vo erview of each medication, its indication, to whom it is administered, and how it works, and treatment settings for medication-assisted treatment. Medications will include: acamprosate, disulfiram, naltrexone, methadone, and buprenorphine. The training will oc nclude with a session on talking to clients about their use of medications, and strategies to address health disparities through increased access to medication-assisted treatment.

At the end of the daylong training, participants will be able to:

1.    Describe at least three (3) acute and chronic effects of alcohol, heroin, and other opioids.
2.    Describe the prevalence of and key populations impacted by alcohol and opioid use disorders.
3.    Provide examples of three (3) medications that are available to treat alcohol and opioid use disorders.
4.    List and explain at least two strategies that can be used to address health disparities through increased access to medication-assisted treatment.

5.    Identify and describe a medication that can be used to reverse overdoses in opioid using individuals